Dehydroepiandrosterone Sulfate
"Dehydroepiandrosterone Sulfate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The circulating form of a major C19 steroid produced primarily by the ADRENAL CORTEX. DHEA sulfate serves as a precursor for TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE.
| Descriptor ID |
D019314
|
| MeSH Number(s) |
D04.210.500.054.079.429.625.300 D04.210.500.578.502.400.300 D06.472.040.502.400.300 D06.472.334.851.968.952.300
|
| Concept/Terms |
Dehydroepiandrosterone Sulfate- Dehydroepiandrosterone Sulfate
- Sulfate, Dehydroepiandrosterone
- Prasterone Sulfate
- Sulfate, Prasterone
- DHA Sulfate
- Sulfate, DHA
- Dehydroisoandrosterone Sulfate
- Sulfate, Dehydroisoandrosterone
- DHEA Sulfate
- Sulfate, DHEA
|
Below are MeSH descriptors whose meaning is more general than "Dehydroepiandrosterone Sulfate".
Below are MeSH descriptors whose meaning is more specific than "Dehydroepiandrosterone Sulfate".
This graph shows the total number of publications written about "Dehydroepiandrosterone Sulfate" by people in this website by year, and whether "Dehydroepiandrosterone Sulfate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dehydroepiandrosterone Sulfate" by people in Profiles.
-
Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J Clin Endocrinol Metab. 2008 Feb; 93(2):534-8.
-
13-cis-Retinoic acid (isotretinoin) unmasking of clinical polycystic ovary syndrome. Endocr Pract. 2007 Nov-Dec; 13(7):776-9.
-
Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess. Fertil Steril. 2005 Feb; 83(2):371-5.
-
High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy. Surgery. 2001 Dec; 130(6):947-53.
-
Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity. Am J Obstet Gynecol. 1992 Dec; 167(6):1813-8.
-
Declining adrenal androgens: an association with bone loss in aging women. Proc Soc Exp Biol Med. 1987 Dec; 186(3):355-60.